Loading market data...
Latest Top News
Show more
Alembic Pharma Reports Strong Q3 Results With Solid Profit Growth
Alembic Pharmaceuticals Ltd posted consolidated revenue from operations of 18.76 billion rupees and a net profit of 1.33 billion rupees for the December quarter. The results highlight strong demand across therapeutic segments, operational efficiency, and resilience in global markets, reinforcing Alembic’s position in India’s pharmaceutical industry.
Stay Ahead – Explore Now! Hindustan Unilever Declares ₹19 Dividend as Q2 Profit Hits ₹26.9 Billion on Robust Sales






